Addressing the question whether reduced hepatic GH action in NAFLD might contribute to frequently found glucose intolerance, we investigated GH metabolism in liver biopsies of patients at various stages of NAFLD. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.